Document is current
Any future updates will be listed below
-
Authors
Misek, Sean A.
Fultineer, Aaron
Kalfon, Jeremie https://orcid.org/0000-0002-2818-9728
Noorbakhsh, Javad
Boyle, Isabella https://orcid.org/0000-0002-8138-1225
Roy, Priyanka
Dempster, Joshua https://orcid.org/0000-0002-3634-9576
Petronio, Lia
Huang, Katherine
Saadat, Alham
Green, Thomas
Brown, Adam
Doench, John G. https://orcid.org/0000-0002-3707-9889
Root, David E. https://orcid.org/0000-0001-5122-861X
McFarland, James M. https://orcid.org/0000-0001-9978-480X
Beroukhim, Rameen https://orcid.org/0000-0001-6303-3609
Boehm, Jesse S. https://orcid.org/0000-0002-6795-6336
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (WX81XWH-21-1-0934, W81XWH-21-1-0901)
Alex's Lemonade Stand Foundation for Childhood Cancer
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 20 May 2024
First Online: 7 June 2024
Competing interests
: R.B. owns equity in and consults for Scorpion Therapeutics and receives grant funding from Novartis. All remaining authors declare no competing interests.
